Results 151 to 160 of about 5,512 (205)

Placebo-Controlled Trial of Tecovirimat for Endemic (Clade I MPXV) mpox, DRC

BACKGROUND: Tecovirimat is available for mpox treatment in Europe and the US, based on animal efficacy studies and safety evaluations in healthy humans. Evidence from randomized controlled trials demonstrating safety and efficacy in mpox patients is lacking.
Ali, Rosine, Alonga, Jules, Biampata, Jean-Luc, Basika, Michael Kombozi, Berry, Irina Maljkovic, Bisento, Nella, Blum, Emily, Bonnett, Tyler, Cone, Katherine, Crozier, Ian, Davey, Richard, Dilu, Ali, Dodd, Lori E., Gulati, Iman, Hruby, Dennis, Ibanda, Augustin, Isse, Francis, Kasareka, Sylva Sivasingana, Kayembe, Gaby, Kojan, Richard, Luzolo, Esaie Kindombe, Lane, H. Clifford, Lawanga, Leader, Liesenborghs, Laurens, Lunghe, Claude Shosongo, Lula, Yves, Lusakibanza, Mariano, Lutete, Gaston Tona, Mbala, Placide, Miranda, Alejandra, Mukadi-Bamuleka, Daniel, Mukendi, Gael, Lupola, Patrick Mutombo, Muyembe, Jean-Jacques, Ndungunu, Robin, Nganga, Bruce, Ntamabyaliro, Nsengi, Nussenblatt, Veronique, Omulepu, Imoite, Onosomba, John Omalokoho, Proschan, Michael, Rubenstein, Kevin, Saknite, Inga, Schechner, Adam, Shaw-Saliba, Kathryn, Sivahera, Billy, Smolskis, Mary, Tillman, Amy, Tkaczyk, Eric, Tshimanga, Celestin, Mbaya, Olivier Tshiani, Tshomba, Antoine, Tshomba, Freddy Yemba Unda, Vallee, David, Vogel, Susan, Weyers, Shera   +55 more
openaire   +1 more source

The effect of volume of interest definition on quantification of lymph node immune response to a monkeypox virus infection assessed by F-FDG-PET [PDF]

core   +1 more source

MPXV RNA-seq data provide evidence for protection of viral transcripts from APOBEC3 editing. [PDF]

J Virol
Lyskova AO, Abasov RK, Pavlova A, Matveev EV, Madorskaya AV, Kazanov FM, Garshina DV, Smolnikova AE, Ponomarev GV, Sharova EI, Ivankov DN, Adebali O, Gelfand MS, Kazanov MD.   +13 more
europepmc   +1 more source

Robust Adaptive Immunity to MPXV in Older People Who Received Childhood Vaccinia Vaccination. [PDF]

Biology (Basel)
Davis C, Zuo J, Bruton R, Hodges M, Roberts T, Manali M, Olmo P, Willett B, Moss P, Parry H.   +9 more
europepmc   +1 more source

Airborne transmission of MPXV and its aerosol dynamics under different viral load conditions

The Lancet Microbe, 2023
openaire   +2 more sources

Pathogenicity and transmissibility of Mpox virus in African dormice. [PDF]

Microbiol Spectr
Chen Z, Zhang L, Li L, Shao M, Zhao Z, Shang C, Liu Z, Liu J, Liu Y, Li X, Guo Z.   +10 more
europepmc   +1 more source

Sero-genomic evidence for occult mpox exposure in healthy Nigerian adults. [PDF]

Nat Commun
Abdullahi A, Omah I, Kassanjee R, Ige F, Edun M, Osawe S, Koofhethile CK, Wisso H, Onyemata EJ, Parker E, Folarin O, Isaac AM, Saulawa UA, Ceron-Gutierrez L, Okpokoro E, Happi A, Sokolova O, Audu R, Aliyu SH, Charurat M, Happi C, Salako BL, Doffinger R, Abimiku A, Gupta RK.   +24 more
europepmc   +1 more source

The Emerging Threat of Monkeypox: An Updated Overview. [PDF]

Viruses
Yahya G, Mohamed NH, Wadan AS, Castro EM, Kamel A, Abdelmoaty AA, Alsadik ME, Martinez-Sobrido L, Mostafa A.   +8 more
europepmc   +1 more source

Monkeypox Virus Antibodies in Healthy Persons after Vaccination with MVA-BN, United Kingdom. [PDF]

Emerg Infect Dis
Sheridan VH, Duffy CW, Dunning J, Turtle L, Hiscox JA, Subramaniam KS, ISARIC4C Investigators.   +6 more
europepmc   +1 more source

Targeted metagenomics reveals hidden chickenpox epidemic amid Mpox surveillance in Uganda. [PDF]

Sci Rep
Kanyerezi S, Ayitewala A, Kabahita JM, Oundo HR, Sseruyange J, Tenywa W, Tusabe G, Were S, Murungi M, Nabukyu M, Nakintu V, Makoha C, Sserwadda I, Onywera H, Tanui C, Mugerwa I, Kagirita A, Lubwama B, Michael ER, Kateete DP, Otita M, Giduddu S, Jjingo D, Nsawotebba A, Mboowa G, Ssemaganda A, Nabadda S, Tessema SK, Ssewanyana I.   +28 more
europepmc   +1 more source